Metropolis Healthcare, India’s second-largest and one of its most trusted pathology chains, has received a patent from the Patent Office, Government of India, for its invention titled “System and Method for Monitoring and Managing Mycobacterium Species-Related Infections.” This patent marks a significant milestone for the company as it strengthens its scientific innovation portfolio.
A Structured Approach to TB Evaluation
As reported by Express Healthcare, the newly patented method introduces a structured, data-driven framework that supports clinicians in diagnosing and managing tuberculosis and other mycobacterial infections. It brings together microbiology results, molecular diagnostic findings, radiology assessments, and individual patient risk factors. By integrating these diverse insights into a single, algorithm-enabled pathway, the method enhances interpretation and promotes greater consistency—particularly in settings where accuracy is paramount.
Leadership Highlights the Milestone
Commenting on the achievement, Surendran Chemmenkotil, Managing Director, Metropolis Healthcare Limited, said, “This is a proud moment for Metropolis as we receive our first patent, an important milestone that reflects our continued commitment to scientific rigor and purposeful innovation. The method recognized under this patent is intended to enhance TB evaluation and offer clinicians an added layer of support in complex decision pathways. As India advances toward its TB elimination goals, we hope this development contributes meaningfully, especially in communities with high disease burden.”
Supporting India’s TB Elimination Mission
India continues to make substantial progress under the National Tuberculosis Elimination Programme (NTEP), driven by better detection, reporting, and treatment outcomes. Diagnostic innovations that streamline clinical workflows and organize data coherently play a crucial role in accelerating these national public health goals.
Strengthening Clinical Decision-Making
Dr. Kirti Chadha, Chief Scientific and Innovation Officer, Metropolis Healthcare Limited, added, “Early and accurate diagnosis remains essential to improving TB outcomes. This patented system is built on a robust scientific foundation, integrating diagnostic signals into a framework that supports clearer clinical assessment. Our aim is to provide physicians with structured, evidence-supported insights that help them make more precise and confident decisions.”
Advancing Public Health Through Innovation
This achievement reinforces Metropolis Healthcare’s commitment to advancing diagnostic science in areas of major public health importance. It aligns with national initiatives like the TB Mukt Bharat Abhiyaan. It offers solutions that support timely, effective patient care.